Chemours, one of the largest U.S. makers of fluorinated chemicals, agreed on June 24 to spend more than $450 million to resolve government claims that it polluted three states' rivers with so-called forever chemicals — a deal the Justice Department called the first comprehensive federal settlement with a PFAS manufacturer.

What Chemours will pay

The agreement, announced by the Justice Department and the Environmental Protection Agency, is built mostly from cleanup obligations rather than fines. Chemours will pay a civil penalty of $22.5 million. On top of that, it will install pollution controls for water discharges and air emissions at its Washington Works plant in West Virginia, at an estimated cost of $60 million; supply clean drinking water for more than a decade to communities near its West Virginia and New Jersey facilities, estimated at $280 million; and evaluate and install controls to cut PFAS releases at its Fayetteville Works plant in North Carolina. Combined, the EPA said, the penalty and required programs are expected to exceed $450 million.

The settlement covers four Chemours facilities and resolves alleged violations of the Clean Water Act and other federal and state environmental laws. The EPA alleges Chemours discharged PFAS into the Ohio River in West Virginia, the Cape Fear River in North Carolina and the Delaware River in New Jersey — in some cases without the required permits, and in others in breach of them.

What PFAS are, and why they cost so much

PFAS — per- and polyfluoroalkyl substances — are a family of thousands of synthetic compounds used since the 1940s in products from non-stick coatings and food packaging to firefighting foam. The carbon-fluorine bonds at their core are among the strongest in chemistry, so the compounds barely break down in the environment or the human body. That persistence is the source of the nickname "forever chemicals."

Research has linked PFAS exposure to elevated risks of certain cancers, thyroid and immune effects, and reproductive harm. In 2024 the EPA set the first enforceable national drinking-water limits for several PFAS compounds at four parts per trillion — a threshold low enough to require specialized filtration, and one that has pushed water utilities toward large new treatment costs. One compound at issue in the Chemours case is GenX, which the company adopted as a replacement for an older PFAS chemical but which later turned up in drinking water near its North Carolina plant.

A DuPont inheritance

Chemours' exposure traces back to its corporate parent. The company was spun off from DuPont in 2015 and took with it DuPont's legacy fluorochemicals business and the plants that had produced PFAS for decades. A spinoff separates a unit into its own public company; in this case it also carried the environmental liabilities of that unit.

The settlement does not close the book on PFAS costs for the broader corporate family. It does not resolve DuPont's own liability for past conduct, and DuPont has separately faced large state claims, including a New Jersey agreement valued at up to $2 billion. Across the industry, PFAS settlements have been mounting: 3M agreed in 2023 to pay up to $10.3 billion to U.S. public water systems, and DuPont, Chemours and Corteva reached a separate $1.185 billion utility settlement the same year.

Not everyone is satisfied

The reception to Wednesday's deal was mixed. North Carolina Attorney General Jeff Jackson criticized the agreement, calling it "an insult to the people of eastern North Carolina" — a region around the Cape Fear River that has spent years and hundreds of millions of dollars filtering PFAS from its water. EPA Administrator Lee Zeldin framed the settlement as designed to make compliance "achievable" for affected drinking-water systems.

For investors, the deal puts a concrete number on one slice of Chemours' PFAS exposure while leaving the wider liability landscape — for Chemours and its corporate relatives — unresolved. The cleanup obligations will be spread over years, but the settlement is another marker in a slow, expensive reckoning for the companies that made forever chemicals.